Table 2.

Selected characteristics of the PAD study cohort, by revascularization status

	Total (n=60)	%	NV (n=25)	%	RV (n=35)	%	P-value
Sex
Male	40	66.7	18	72.0	22	62.9
Female	20	33.3	7	28.0	13	37.1	0.581
Age (mean ± SD)	68.7±10.7		67.8±10.4		69.3±11.1		0.587
Race/ethnicity
White, non-Hispanic	53	88.3	22	88.0	31	88.6
Non-white	7	11.7	3	12.0	4	11.4	0.642
Annual household income
<$20,000	10	17.0	4	16.0	6	17.1
$20,000–$39,999	14	23.7	5	20.0	9	25.7
$40,000–$59,999	12	20.3	5	20.0	7	20.0
>$60,000	23	39.0	11	44.0	12	34.3	0.919
Medical history
History of cardiovascular disease	30	50.0	11	44.0	19	54.3	0.601
History of stroke	10	16.7	5	20.0	5	14.3	0.728
Emphysema and/or chronic obstructive pulmonary disease	12	20.0	5	20.0	7	20.0	1.000
Cancer	14	23.3	4	16.0	10	28.6	0.357
Atherosclerosis risk factors
Current smoker	12	20.0	6	24.0	6	17.1	0.337
Former smoker	38	63.3	17	68.0	21	60.0
Never smoker	10	16.7	2	8.0	8	22.9
Type 2 diabetes	21	35.0	8	32.0	13	37.1	0.787
Hypertension	45	75.0	22	88.0	23	65.7	0.071
Obesity diagnosis	10	16.7	4	16.0	6	17.1	1.000
Body mass index
Mean ± SD	28.8±5.6		28.7±5.2		28.9±6.0		0.924
Underweight (<18.5)	0	0.0	0	0.0	0	0.0
Normal (18.5–24.99)	16	26.7	6	24.0	10	28.6
Overweight (25.0–29.99)	20	33.3	8	40.0	12	34.3
Obese class I (30.0–34.99)	19	31.7	10	32.0	9	25.7
Obese class II (35.0–39.99)	2	3.3	0	0.0	2	5.7

Note: Participants with a history of 1+ endovascular or operative procedures were categorized as RV versus participants with NV.

Abbreviations: PAD, peripheral arterial disease; RV, revascularized; NV, native vasculature.